Illinois · House Bill 3454 · 104th General Assembly

EPINEPHRINE DELIVERY DEVICE

  1. Introduced Feb 7, 2025
  2. In committee Feb 18, 2025
  3. Passed the House Feb 25, 2026
  4. Passed the Senate May 28, 2026
  5. To the governor Jun 26, 2026
  6. Became law Aug 7, 2026

What it does

The legislature's own summary of the bill, or its official long title.

Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.

Every action

56 steps, oldest first, as the legislature records them.

Show the 48 earlier steps
  1. HouseFiled with the Clerk by Rep. Joyce Mason
  2. HouseFirst Reading
  3. CommitteeReferred to Rules Committee · House Rules
  4. CommitteeAssigned to Prescription Drug Affordability & Accessibility Committee · House Prescription Drug Affordability
  5. CommitteeDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000 · House Prescription Drug Affordability
  6. HousePlaced on Calendar 2nd Reading - Short Debate
  7. HouseAdded Co-Sponsor Rep. Jawaharial Williams
  8. HouseAdded Co-Sponsor Rep. Harry Benton
  9. HouseAdded Co-Sponsor Rep. Dagmara Avelar
  10. HouseSecond Reading - Short Debate
  11. HouseHeld on Calendar Order of Second Reading - Short Debate
  12. HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  13. CommitteeRule 19(a) / Re-referred to Rules Committee · House Rules
  14. HouseAdded Chief Co-Sponsor Rep. Martha Deuter
  15. CommitteeApproved for Consideration Rules Committee; 005-000-000 · House Rules
  16. HousePlaced on Calendar 2nd Reading - Short Debate
  17. HousePlaced on Calendar Order of 3rd Reading - Short Debate
  18. HouseThird Reading - Short Debate - Passed 105-000-000
  19. SenateArrive in Senate
  20. SenatePlaced on Calendar Order of First Reading March 3, 2026
  21. HouseAdded Co-Sponsor Rep. Michelle Mussman
  22. HouseAdded Chief Co-Sponsor Rep. Janet Yang Rohr
  23. SenateChief Senate Sponsor Sen. Suzy Glowiak Hilton
  24. SenateFirst Reading
  25. CommitteeReferred to Assignments · Senate Assignments
  26. CommitteeAssigned to Insurance · Senate Insurance
  27. SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak Hilton
  28. CommitteeSenate Committee Amendment No. 1 Referred to Assignments · Senate Assignments
  29. CommitteeDo Pass Insurance; 009-000-000 · Senate Insurance
  30. SenatePlaced on Calendar Order of 2nd Reading May 7, 2026
  31. SenateSecond Reading
  32. SenatePlaced on Calendar Order of 3rd Reading May 18, 2026
  33. SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak Hilton
  34. CommitteeSenate Floor Amendment No. 2 Referred to Assignments · Senate Assignments
  35. CommitteeSenate Floor Amendment No. 2 Be Approved for Consideration Assignments · Senate Assignments
  36. SenateRule 2-10 Third Reading Deadline Established As May 31, 2026
  37. SenateRecalled to Second Reading
  38. SenateSenate Floor Amendment No. 2 Adopted; Glowiak-Hilton
  39. SenatePlaced on Calendar Order of 3rd Reading
  40. SenateThird Reading - Passed; 059-000-000
  41. SenateSenate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
  42. SenateAdded as Alternate Co-Sponsor Sen. Mary Edly-Allen
  43. HouseArrived in House
  44. HousePlaced on Calendar Order of Concurrence Senate Amendment(s) 2
  45. HouseSenate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce Mason
  46. CommitteeSenate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee · House Rules
  47. HouseAdded Chief Co-Sponsor Rep. Natalie A. Manley
  48. CommitteeSenate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee · House Prescription Drug Affordability
  1. CommitteeSenate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000 · House Prescription Drug Affordability
  2. HouseSenate Floor Amendment No. 2 House Concurs 116-000-000
  3. HouseHouse Concurs
  4. HousePassed Both Houses
  5. HouseSent to the Governor
  6. HouseGovernor Approved
  7. HouseEffective Date January 1, 2027
  8. HousePublic Act . . . . . . . . . 104-0762

Roll calls

6 recorded votes: 3 on the floor, 3 in committee. Each shows how every member voted.

Third Reading · Full House

Passed 105–0
Feb 25, 2026 · journal entry
Yes 105 No 0 Not voting 13
Democrats: 69 yes, 0 no Republicans: 36 yes, 0 no
How each member voted

Yes · 105

Not voting · 2

Absent · 6

Excused · 5

Third Reading · Full Senate

Passed 59–0
May 28, 2026 · journal entry
Yes 59 No 0
Democrats: 40 yes, 0 no Republicans: 19 yes, 0 no
How each member voted

Yes · 59

Senate Floor Amendment No. 2 - Concurrence · Full House

Passed 116–0
May 31, 2026 · journal entry
Yes 116 No 0 Not voting 2
Democrats: 77 yes, 0 no Republicans: 39 yes, 0 no
How each member voted

Yes · 116

Not voting · 1

Excused · 1

Committee and other votes

DateWhereQuestionResult
Mar 19, 2025 House Prescription Drug Affordability Prescription Drug Affordability - Do Pass
Members

Yes · 13

Not voting · 1

Passed 13–0
May 5, 2026 Senate Insurance Insurance - Do Pass
Members

Yes · 9

Not voting · 5

9–0
May 29, 2026 House Prescription Drug Affordability Senate Floor Amendment No. 2 - Prescription Drug Affordability - Recommends Be Adopted
Members

Yes · 13

Passed 13–0

Sponsors

The member who introduced it, joined by 9 cosponsors: 9 Democrats.

All 9 cosponsors

From Illinois's official records (www.ilga.gov), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.